What Happens to the Other Vaccines Now?
Pfizer’s success creates an ethical dilemma for other clinical trials. Read Article
Pfizer’s success creates an ethical dilemma for other clinical trials. Read Article
Dr. Stephenson clarifies why these results are noteworthy. Read Article
Dr. Barouch talks to the Bloomberg about many ways the body responds to infections/viruses. Read Article
Our very own, Dr. Reeves, will be assuming Co-Editor-in-Chief of AIDS Research and Human Retroviruses starting November of 2020. Press Release
Our very own director, Dr. Dan barouch, has been elected to the National Academy of Medicine. ” For being an international leader in virology and immunology and developing novel vaccines and cure strategies for viruses of global importance, including working on one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies. ” Press Release

A unique treatment course may have blunted his body’s production of antibodies, scientists warn. Read Article
“Which vaccine or vaccines will prove the safest and the most effective and the most deployable? I think we don’t know yet. And that’s why having redundancy is good,” says Dan Barouch. Read Article

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
